Evaluation of Known or Suspected Cardiac Sarcoidosis

Area of Science:

• Cardiology
• Immunology
• Radiology

Background:

• Sarcoidosis is a multisystem inflammatory disease of unknown etiology.
• Cardiac sarcoidosis (CS) affects at least 25% of sarcoidosis patients, contributing significantly to morbidity and mortality.
• CS manifestations include heart failure, arrhythmias, and sudden cardiac death, posing diagnostic challenges due to focal disease and limited clinical criteria accuracy.

Purpose of the Study:

• To review the role of various imaging modalities in the evaluation and management of cardiac sarcoidosis.
• To highlight the importance of integrating clinical and imaging findings for improved CS diagnosis.

Main Methods:

• Review of existing literature on cardiac sarcoidosis diagnosis and management.
• Discussion of the utility of different imaging techniques (e.g., echocardiography, cardiac MRI, PET scans) in detecting cardiac involvement.
• Emphasis on the combined diagnostic value of clinical assessment and imaging results.

Main Results:

• Cardiac sarcoidosis diagnosis is often difficult due to its focal nature and limitations of clinical criteria.
• Imaging modalities play a crucial role in identifying myocardial inflammation and fibrosis characteristic of CS.
• Integration of clinical data with imaging findings significantly enhances diagnostic accuracy.

Conclusions:

• Accurate diagnosis and timely management of cardiac sarcoidosis are critical for improving patient outcomes.
• Multimodality imaging is essential for the comprehensive evaluation of patients with known or suspected cardiac sarcoidosis.
• A combined approach utilizing clinical expertise and advanced imaging techniques is key to effectively managing cardiac sarcoidosis.